https://www.selleckchem.com/pr....oducts/ory-1001-rg-6
001), percutaneous coronary intervention (1.7% vs. 38.5%; p0.001), and coronary artery bypass grafting (0.4% vs. 7.8%; p0.001) were lower among type 2 MI patients. Patients with type 2 MI had lower risk of in-hospital mortality (adjusted odds ratio 0.57 [95% confidence interval 0.54 to 0.60]) and 30-day MI readmission (adjusted odds ratio 0.46 [95% confidence interval 0.35 to 0.59]). There was no difference in risk of 30-day all-cause or heart failure readmission. Patients with type 2 MI have a unique cardiovascular phe
Like
Comment
Share
